Retractable Technologies, Inc. Wins a Round Against Becton, Dickinson and Company

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A federal judge rules that patent infringement can be anti-competitive in an anti-trust lawsuit filed against Becton Dickinson by Retractable Technologies. Becton Dickinson & Co. (NYSE:BDX) lost its bid to toss anti-trust claims stemming from patent infringement in a lawsuit filed by Retractable Technologies (NYSE:RVP), after a federal judge ruled that infringement could constitute anti-competitive behavior. The case, which went before a Texas jury yesterday, is the latest in a long-running patent battle between the companies, which began when Texas-based Retractable Technologies sued on allegations that Becton's Integra syringes infringe patents covering its competing VanishPoint devices.

Help employers find you! Check out all the jobs and post your resume.

Back to news